Pathogenesis of bone loss in heart transplant candidates and recipients

Journal of Heart and Lung Transplantation

Volumn 22, Issue 8, 2003, Pages 843-850

  Kerschan Schindl, Katharina ^a,b   Strametz Juranek, Jasmine ^a   Heinze, Georg ^a   Grampp, Stephan ^a   Bieglmayer, Christian ^a   Pacher, Richard ^a   Maurer, Gerald ^a   Fialka Moser, Veronika ^a   Pietschmann, Peter ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; COLLAGEN TYPE 1; CORTISONE; CREATININE; ESTRADIOL; OSTEOCALCIN; PEPTIDE DERIVATIVE; THYROTROPIN; THYROXINE; UREA;

ADULT; ARTICLE; BIOCHEMISTRY; BONE ATROPHY; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CROSS LINKING; HEART TRANSPLANTATION; HUMAN; KIDNEY FUNCTION; ORGAN DONOR; OSTEOLYSIS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECIPIENT; STATISTICAL SIGNIFICANCE; UREA BLOOD LEVEL;

EID: 0042666846     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(02)00806-9     Document Type: Article

References (42)

1. Anonymous. Consensus development conference: prophylaxisand treatment of osteoporosis. Am J Med 1991;90:107-10.
2. Van Cleemput J., Daenen W., Nijs J., Geusens P., Dequeker J., Vanhaecke J. Timing and quantification of bone loss in cardiac transplant recipients. Transpl Int. 8:1995;196-200.
3. Rico H., Revilla M., Hernandez E.R., Villa L.F., Del Buergo M.A., Alonso A.L. Age-and weight-related changes in total body bone mineral in men. Miner Electrolyte Metab. 17:1991;321-323.
4. Grampp S., Genant H.K., Mathur A., et al. Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification. J Bone Miner Res. 12:1997;697-711.
5. Shane E., Rivas M., Kim T.S., Staron R.B., Bilezikian J.P. Osteoporosis after cardiac transplantation. Am J Med. 94:1993;257-264.
6. Shane E., Rivas M., McMahon D.J., et al. Bone loss and turnover after cardiac transplantation. J Clin Endocrinol Metab. 82:1997;1497-1506.
7. Sambrook P.N., Kelly P.J., Fontana D., et al. Mechanisms of rapid bone loss following cardiac transplantation. Osteoporos Int. 4:1994;273-276.
8. Guo C.Y., Johnson A., Locke T.J., Eastell R. Mechanisms of bone loss after cardiac transplantation. Bone. 22:1998;267-271.
9. Glendenning P., Kent G.N., Adler B.D., et al. High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry. Clin Endocrinol. 50:1999;347-355.
10. Välimäki M.J., Kinnunen K., Tähtelä R., et al. A prospective study of bone loss and turnover after cardiac transplantation effect of calcium supplementation with or without calcitonin . Osteoporos Int. 10:1999;128-136.
11. Stempfle H.U., Werner C., Echtler S., et al. Prevention of osteoporosis after cardiac transplantation. Transplantation. 68:1999;523-530.
12. Thièbaud D., Krieg M.A., Gillard-Berguer D., Jacquet A.F., Goy J.J., Burckhardt P. Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation. Eur J Clin Invest. 26:1996;549-555.
13. Ramirez G., Narvarte J., Bittle P.A., Ayers-Chastain C., Dean S.E. Cyclosporine-induced alterations in the hypothalamic hypophyseal gonadal axis in transplant patients. Nephron. 58:1991;27-32.
14. Lee A.H., Mull R.L., Keenan G.F., et al. Osteoporosis and bone morbidity in cardiac transplant recipients. Am J Med. 96:1994;35-41.
15. Muchmore J.S., Cooper D.K., Schlegel V., Pribil A., Zuhdi N. Prevention of loss of vertebral bone density in heart transplant patients. J Heart Lung Transplant. 11:1992;959-963.
16. Canver C.C., Heisey D.M., Nichols R.D. Acute renal failure requiring hemodialysis immediately after heart transplantation portends a poor outcome. J Cardiovasc Surg. 41:2000;203-206.
17. Kanis J.A., Melton L.J., Christiansen C., Johnston C.C., Khaltaev N. Perspective the diagnosis of osteoporosis . J Bone Miner Res. 9:1994;1137-1141.
18. Shane E., Mancini D., Aaronson K., Silverberg S.J. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med. 103:1997;197-207.
19. Reichel H., Deibert B., Schmidt-Gayk H., Ritz E. Calcium metabolism in early chronic renal failure implications for the pathogenesis of hyperparathyroidism . Nephrol Dial Transplant. 6:1991;162-169.
20. Kriegsman D.M., Deeg D.J., van-Eijk J.T., Pennix B.W., Boeke A.J. Do disease specific characteristics add to the explanation of mobility limitations in patients with different chronic disease? J Epidemiol Community Health. 51:1997;676-685.
21. Albanese M.C., Plewka M., Gregori D., et al. Use of medical resources and quality of life of patients with chronic heart failure a prospective survey in a large Italian community hospital . Eur J Heart Fail. 1:1999;411-417.
22. Bischoff H., Stahelin H.B., Vogt P., et al. Immobility as a major cause of bone remodelling in residents of a long-stay geriatric ward. Calcif Tissue Int. 64:1999;485-489.
23. Dzau V.J. Renal and circulatory mechanisms in congestive heart failure. Kidney Int. 31:1987;1402-1415.
24. Link T.M., Lotter A., Beyer F., et al. Changes in calcaneal trabecular cone structure after heart transplantation an MR imaging study . Radiology. 217:2000;855-863.
25. Grampp S., Henk C.B., Fuerst T.P., et al. Diagnostic agreement of quantitative sonography of the calcaneus with dual X-ray absorptiometry of the spine and femur. AJR Am J Radiol. 173:1999;329-334.
26. Sambrook P.N., Kelly P.J., Keogh A.M., et al. Bone loss after heart transplantation a prospective study . J Heart Lung Transplant. 13:1994;116-121.
27. Shin W.Y., Li S.Z., Chung S.S., Lee H.C., Huh K.B., Lim S.K. Effects of cyclosporine A on sex hormone and estrogen receptor in male rat with special reference to cyclosporine A-induced osteoporosis. Yonsei Med J. 41:2000;61-67.
28. Szulc P., Munoz F., Claustrat B., et al. Bioavailable estradiol may be an important determinant of osteoporosis in men the MINOS study . J Clin Endocrinol Metab. 86:2001;192-199.
29. Pietschmann P., Kudlacek S., Grisar J., et al. Bone turnover markers and sex hormones in men with ideopathic osteoporosis. Eur J Clin Invest. 31:2001;444-451.
30. Goral S., Ynares C., Shyr Y., Yeoh T.K., Johnson H.K. Long-term renal function in heart transplant recipients receiving cyclosporine therapy. J Heart Lung Transplant. 16:1997;1106-1112.
31. Kemink S.A.G., Hermus R., Swinkels L.M., Lutterman J.A. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology. J Endocrinol Invest. 23:2000;295-303.
32. Heaf J., Tvedegaard E., Kanstrup I.L., Fogh-Andersen N. Bone loss after renal transplantation role of hyperparathyroidism, acidosis, cyclosporine and systemic disease . Clin Transplant. 14:2000;457-463.
33. Kokado Y., Takahara S., Ichimaru N., et al. Factors influencing vertebral bone density after renal transplantation. Transplant Int. 13:2000;S431-435.
34. Monegal A., Navasa M., Guanabens N., et al. Bone disease after liver transplantation a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics . Osteoporos Int. 12:2001;484-492.
35. Sabbatini M., De Nicola L., Uccello F., et al. Absence of acute nephrotoxicity with low doses of cyclosporine experimental study in the rat . Nephrol Dial Transplant. 5:1990;69-74.
36. Bowman A.R., Sass D.A., Dissanayake I.R., et al. The role of testosterone in cyclosporine-induced osteopenia. J Bone Miner Res. 12:1997;607-615.
37. Epstein S. Cyclosporine A friend or foe? Calcif Tissue Int. 49:1991;232-234.
38. Schneider D.L., Barett-Connor E.L. Urinary N-telopeptide levels discriminate normal, osteopenic, and osteoporotic bone mineral density. Arch Int Med. 157:1997;1241-1245.
39. Orwoll E.S., Bell N.H., Nanes M.S., et al. Collagen N-telopeptide excretion in men the effects of age and intrasubject variability . J Clin Endocrin Metab. 83:1998;3930-3935.
40. Khosla S., Melton L.J., Atkinson E.J., O'Fallon W.M., Klee G.G., Riggs B.L. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women a key role for bioavailable estrogen . J Clin Endocrinol Metab. 83:1998;2266-2274.
41. Gallagher J.C., Kinyamu H.K., Fowler S.E., Dawson-Huges B., Dalsky G.P., Sherman S.S. Calciotropic hormones and bone markers in the elderly. J Bone Miner Res. 13:1998;475-482.
42. Tsai K.S., Pan W.H., Hsu S.H.J., et al. Sexual differences in bone markers and bone mineral density of normal Chinese. Calcif Tissue Int. 59:1996;454-460.